Allarity-backed SPAC files S-1 for $100M IPO
Allarity Therapeutics said a SPAC sponsor filed an S-1 for a proposed $100 million IPO, with up to $115 million including overallotment. The sponsor is expected to own about 25% after the offering.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.